Toronto, Ontario, Canada In 2005 was created Ontario Institute for Cancer Research, which is appeared as Corporate Investor. The venture was found in North America in Canada. The leading representative office of defined Corporate Investor is situated in the Toronto.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Analytics, Software. Among the most popular portfolio startups of the fund, we may highlight Privacy Analytics.
The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2014. The top amount of exits for fund were in 2016. Deals in the range of 1 - 5 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Ontario Institute for Cancer Research, startups are often financed by MaRS Investment Accelerator Fund, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are Vanedge Capital, Business Development Bank of Canada, BDC Venture Capital.
Related Funds
| Fund Name | Location |
| BFI, LLC. | New York, New York, United States |
| Cambridge Information Systems | Cambridge, Massachusetts, United States |
| EFG Hermes | Al Qahirah, Cairo, Egypt |
| Ganzhen Touzi | China, Guangdong, Shenzhen |
| Hillcrest Venture Partners | California, Glendale, United States |
| Medavinci | Amsterdam, Noord-Holland, The Netherlands |
| Persistent Systems | India, Maharashtra, Pune |
| Ruidong Capital | Chengguan District, China, Lhasa |
| SH Group | California, Los Angeles, United States |
| Tennessee Community Ventures | Nashville, Tennessee, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Privacy Analytics | $3M | 21 Jul 2014 | (Old) Ottawa, Ontario, Canada | ||
XLV Diagnostics | 01 Jan 2013 | Thunder Bay, Ontario |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Privacy Analytics | $3M | 21 Jul 2014 | (Old) Ottawa, Ontario, Canada | ||
XLV Diagnostics | 01 Jan 2013 | Thunder Bay, Ontario |
